Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE2/PHASE3

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Goal of this project is to integrate a previously-tested internet-facilitated Screening, Brief Intervention, and Referral to Treatment (iSBIRT) system for adolescent substance use into a large network of primary care offices, the Pediatric Practices of Children's Hospital Boston (PPOC).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use

NCT01275391

Tobacco Abuse Alcohol Abuse Drug Abuse

WITHDRAWN PHASE1/PHASE2

Advancing Adolescent Screening and Brief Intervention Protocols in Primary Care Settings

NCT01523444

Substance Abuse

WITHDRAWN PHASE3

Validating Adolescent SBIRT Measures

NCT02981849

Substance Abuse

COMPLETED

Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education

NCT00612482

Substance Abuse

COMPLETED PHASE1

Reducing Problematic Substance Use in Youth With Chronic Medical Conditions

NCT01709201

Alcohol Abuse Drug Abuse

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment as Usual

Group Type NO_INTERVENTION

No interventions assigned to this group

iSBIRT

Participants will receive the internet-facilitated screening, brief intervention and referral to treatment (iSBIRT intervention)

Group Type EXPERIMENTAL

iSBIRT

Intervention Type BEHAVIORAL

Participants will be screened for substance use, view information about the health effects of substance use on the computer, and receive advice from the primary care provider regarding the health effects of substance use. Those found to be at "high risk" will complete an internet-based program encouraging them to change their substance use.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iSBIRT

Participants will be screened for substance use, view information about the health effects of substance use on the computer, and receive advice from the primary care provider regarding the health effects of substance use. Those found to be at "high risk" will complete an internet-based program encouraging them to change their substance use.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 12-18 year olds
* Coming for non-emergent care
* Access to a private computer
* Have email address

Exclusion Criteria

* Not available for follow-up questionnaires
* Unable to read or understand English at a 6th grade reading level
* Medically or emotionally unstable on the day of the visit

Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

John R Knight, MD

Associate Professor of Pediatrics, Harvard Medical School; Senior Associate in Medicine; Associate in Psychiatry, Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR